Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-05-26
2009-12-01
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S211090, C514S230500, C514S375000, C514S651000, C540S546000, C546S226000, C548S217000
Reexamination Certificate
active
07625929
ABSTRACT:
The invention relates to the compounds of general formula (I)where R1represents H, a (C1-C4)alkyl, —CO(C1-C4)alkyl, (C1-C4)alkylphenyl or —CO-phenyl group, said phenyl being optionally substituted, R2represents H, a halogen atom, an —S(O)zR3, —NHSO2R3, —NHSO2-phenyl or —NHSO2—(C1-C4)alkylphenyl group where z is equal to 0, 1 or 2 and where R3represents a (C1-C4)alkyl group, said phenyl being optionally substituted;A is chosen fromwhere n is equal to 0, 1 or 2, R4and R5represent H, a (C1-C4)alkyl, hydroxyl, cyano, phenyl, benzyl, piperidyl, —CONH2, —CO-phenyl, —COOR3, —CH(phenyl) (OH) and —C(phenyl)2(OH) group, or R4and R5form together an optionally substituted 6-membered aromatic ring, R6represents H, a (C1-C4)alkyl, phenyl or benzyl group, and B represents a 5- or 6-membered nitrogen-containing heterocycle or homocycle optionally fused with a phenyl Group or optionally substituted; their addition salts; their method of preparation and their therapeutic application.
REFERENCES:
patent: 6130217 (2000-10-01), Arnold et al.
patent: 6770645 (2004-08-01), Denton et al.
patent: 2003/0040538 (2003-02-01), Miyoshi et al.
patent: 2004/0053916 (2004-03-01), Bovy et al.
patent: WO 01/07026 (2001-02-01), None
patent: WO 01/44187 (2001-06-01), None
patent: WO 02/44139 (2002-06-01), None
Arnold et al. “Preparation of . . . ” CA 122:314571 (1995).
Yoshida et al. “Obesity and . . . ” Ca 117:109086 (1992).
Furuya et al. “beta-3-Adrenergic . . . ” CA 136:63350 (2001).
Silverman “The organic chemicstry of drug design . . . ” p. 72-73 ((1993).
Martin et al. :beta-3-adrnoceptor agonists . . . Eur. Resp. J. v.7, p. 1610-1615 (1994).
Strosberg “structure and function of the beta-3-adrenergic receptor” Ann. Rev. Pharmacol. Toxicol. v.37, p. 421-450 (1997).
Braga et al. “Making crystals from . . . ” chem. Commu. (2005) p. 3635-3645.
Derwent Patent Abstract No. 200248 (2004).
Bovy Philippe R.
Cecchi Roberto
Croci Tiziano
Venier Olivier
Chang Celia
Kurys Barbara E.
sanofi-aventis
LandOfFree
Oxophenyl-cyclohexyl-propanolamine derivatives, production... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxophenyl-cyclohexyl-propanolamine derivatives, production..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxophenyl-cyclohexyl-propanolamine derivatives, production... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4141369